Emotional and Cognitive Responses of Children Attending Summer Camps in Occupied Palestine: A Pilot Study

Background: The current study sought to address the lack of evaluation for summer camps which seek to offer emotional and cognitive support for children in occupied Palestine.Objective: To assess children’s emotional and cognitive response to summer camps, children who attended camps were compared to those who did not attend on a standardised measure of emotion and cognition within situations of adversity.Methods: A mixed methods quasi-experimental post-test only design was used.Children, aged 8-10 years, who attended a summer camp (n=62), were compared to those who had not attended a camp (n=22) on the Child Post-traumatic Cognitions Inventory and on a qualitative summer experience questionnaire. Camp workers (n= 16) also completed a summer experiences questionnaire for comparison of perceptions between workers and children. Statistical analysis involved t-test and ANOVA for within and between group differences and a six-step quasi-qualitative analysis was used to assess summer experience questionnaire responses.Results: Unexpectedly,children who had attended a summer camp presented higher levels of traumatic cognition; however, they also reported more hopefulness for the future than children who did not attend a camp. It is uncertain if camp attendees are a self-selecting group because of higher levels of traumatic exposure and/or cognitions or because summer camps may have unintended negative consequences.Conclusion: The current study, with its unexpected results, emphasises the importance of embedding evaluation into summer camp delivery. More robust experimental designs, however, are necessary in order to be confident that the outcomes are related to program rather than contextual factors. A range of potential summer camp and environmental influencing factors on outcomes were identified for future research

Social and political context of summer camps in occupied Palestine:A brief commentary

The unique social and political context of the occupied Palestinian Territories (oPT) hasseveral implications for conducting research there. The cumulative violence of decadesof military occupation has resulted in intergenerational psychological disorders. Due tothe lack of funding and poor economic climate, Palestinians seek psychologicaltreatment through communal and creative outlets. One common method Palestiniancommunities use is summer camps, held across the oPT for children. We investigatedthe cognitive and emotional responses of children attending summer camps, to explorehow effective these camps are in alleviating symptoms of trauma and stress (Oudeh, Nizam, Barron, Abdullah & Willatts, 2014). The current commentary highlights the importance of taking into account the social and political context in which summer camps are delivered. Factors identified for analysis include the geographical situation and the relationship to military violence, the nature and impact of 'area' administrative control, the extent of poverty and dependence on aid, and the local decision-making on the purpose and activities of camps as well as the selection criteria for children who attend camps. Recommendations are provided for future research

Systematic review of fatty acid composition of human milk from mothers of preterm compared to full-term infants

Background: Fatty acid composition of human milk serves as guidance for the composition of infant formulae. The aim of the study was to systematically review data on the fatty acid composition of human milk of mothers of preterm compared to full-term infants. Methods: An electronic literature search was performed in English (Medline and Medscape) and German (SpringerLink) databases and via the Google utility. Fatty acid compositional data for preterm and fullterm human milk were converted to differences between means and 95% confidence intervals. Results: We identified five relevant studies publishing direct comparison of fatty acid composition of preterm versus full-term human milk. There were no significant differences between the values of the principal saturated and monounsaturated fatty acids. In three independent studies covering three different time points of lactation, however, docosahexaenoic acid (DHA) values were significantly higher in milk of mothers of preterm as compared to those of full-term infants, with an extent of difference considered nutritionally relevant. Conclusion: Higher DHA values in preterm than in full-term human milk underlines the importance of using own mother's milk for feeding preterm babies and raises the question whether DHA contents in preterm formulae should be higher than in formulae for full-term infants. Copyright (c) 2008 S. Karger AG, Basel

Understanding the effects of one’s actions upon hidden objects and the development of search behaviour in 7-month-old infants

Infants' understanding of how their actions affect the visibility of hidden objects may be a crucial aspect of the development of search behaviour. To investigate this possibility, 7-month-old infants took part in a two-day training study. At the start of the first session, and at the end of the second, all infants performed a search task with a hiding-well. On both days, infants had an additional training experience. The ‘Agency group’ learnt to spin a turntable to reveal a hidden toy, whilst the ‘Means-End’ group learnt the same means-end motor action, but the toy was always visible. The Agency group showed greater improvement on the hiding-well search task following their training experience. We suggest that the Agency group's turntable experience was effective because it provided the experience of bringing objects back into visibility by one's actions. Further, the performance of the Agency group demonstrates generalized transfer of learning across situations with both different motor actions and stimuli in infants as young as 7 months

Learning object relationships which determine the outcome of actions

Peer reviewedPublisher PD

Maternal docosahexaenoic acid intake levels during pregnancy and infant performance on a novel object search task at 22 months

This study investigated maternal prenatal docosahexaenoic acid (DHA) intake and infant cognitive development at 22 months. Estimates for second- and third-trimester maternal DHA intake levels were obtained using a comprehensive Food Frequency Questionnaire. Infants (n = 67) were assessed at 22 months on a novel object search task. Mothers' DHA intake levels were divided into high or low groups, with analyses revealing a significant positive effect of third-trimester DHA on object search task performance. The third trimester appears to be a critical time for ensuring adequate maternal DHA levels to facilitate optimum cognitive development in late infancy

The roles of long-chain polyunsaturated fatty acids in pregnancy, lactation and infancy: review of current knowledge and consensus recommendations

This paper reviews current knowledge on the role of the long-chain polyunsaturated fatty acids (LC-PUFA), docosahexaenoic acid (DHA, C22:6n-3) and arachidonic acid (AA, 20:4n-6), in maternal and term infant nutrition as well as infant development. Consensus recommendations and practice guidelines for health-care providers supported by the World Association of Perinatal Medicine, the Early Nutrition Academy, and the Child Health Foundation are provided. The fetus and neonate should receive LC-PUFA in amounts sufficient to support optimal visual and cognitive development. Moreover, the consumption of oils rich in n-3 LC-PUFA during pregnancy reduces the risk for early premature birth. Pregnant and lactating women should aim to achieve an average daily intake of at least 200mg DHA. For healthy term infants, we recommend and fully endorse breastfeeding, which supplies preformed LC-PUFA, as the preferred method of feeding. When breastfeeding is not possible, we recommend use of an infant formula providing DHA at levels between 0.2 and 0.5 weight percent of total fat, and with the minimum amount of AA equivalent to the contents of DHA. Dietary LC-PUFA supply should continue after the first six months of life, but currently there is not sufficient information for quantitative recommendation

Symbiosal^®and lowering of blood pressure and reduced risk of hypertension:evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006

Following an application from Han-Biotech GmbH, submitted for authorisation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006 via the Competent Authority of Germany, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to Symbiosal® , lowering of blood pressure and reduced risk of hypertension. The Panel considers that the food, Symbiosal® , which is the subject of the health claim, and the food, table salt, which Symbiosal® should replace, are sufficiently characterised. Lowering of blood pressure is a beneficial physiological effect. Increased blood pressure is a risk factor for hypertension. In weighing the evidence, the Panel took into account that one human study with some methodological limitations showed an effect of Symbiosal® on blood pressure in the context of a self-selected diet with a maximum of 3 g/day added salt. The Panel also took into account that no other human studies in which these results have been replicated were provided, that the animal studies did not support the results of the human study, that no evidence was provided in support of a mechanism by which Symbiosal® could induce a decrease in blood pressure upon oral consumption as compared to table salt in vivo in humans, and the low biological plausibility of the effect observed in the human intervention study. The Panel concludes that a cause and effect relationship has not been established between the consumption of Symbiosal® and lowering of blood pressure. </p

NWT-02, a fixed combination of lutein, zeaxanthin and docosahexaenoic acid in egg yolk and reduction of the loss of vision:evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006

Following an application from Newtricious R&amp;D B.V., submitted for authorisation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 via the Competent Authority of the Netherlands, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to NWT-02 and a reduction of the loss of vision. The food proposed by the applicant as the subject of the health claim is NWT-02. NWT-02 is standardised by its content in lutein (≥ 1.10 mg), zeaxanthin (≥ 0.20 mg) and docosahexaenoic acid (DHA) (≥ 170 mg). The Panel considers that the food/constituent that is the subject of the health claim, NWT-02, a fixed combination of lutein, zeaxanthin and docosahexaenoic acid in egg yolk, is sufficiently characterised. The claimed effect proposed by the applicant is ‘reduces loss of vision’. The target population proposed by the applicant is ‘healthy adults over 50 years of age’. The Panel considers that a reduction of the loss of vision is a beneficial physiological effect. The applicant provided two human intervention studies for the scientific substantiation of the claim. The Panel considers that the only study from which conclusions can be drawn for the scientific substantiation of the claim did not show an effect of NWT-02 on vision. The Panel concludes that a cause and effect relationship has not been established between the consumption of NWT-02, a fixed combination of lutein, zeaxanthin and docosahexaenoic acid in egg yolk, and a reduction of the loss of vision.</p

L-carnitine and contribution to normal lipid metabolism:evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006

Following an application from Lonza Ltd., submitted for authorisation of a health claim pursuant to Article 13(5) of Regulation (EC) No1924/2006 via the Competent Authority of Germany, the EFSA Panelon Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to L-carnitine and normal lipid metabolism. The food that is proposed as the subject of the health claim is L-carnitine. The Panelconsiders that L-carnitine is sufficiently characterised. The claimed effect proposed by the applicant is normal lipid metabolism'. The target population proposed by the applicant is the general population. The Panelconsiders that contribution to normal lipid metabolism is a beneficial physiological effect. The applicant proposes that the claim submitted with this application is based on the essentiality of a nutrient. The Panelconsiders that the evidence provided does not establish that dietary L-carnitine is required to maintain normal lipid metabolism in the target population, for which the claim is intended. The Panelconcludes that a cause and effect relationship has not been established between the consumption of L-carnitine and contribution to normal lipid metabolism in the target population